Hyperbaric Oxygen Therapy Improved Neovascularisation Following Limb Ischaemia-The Role of ROS Mitigation

Hyperbaric oxygen (HBO) therapy has emerged as a potential treatment, shown to enhance blood flow and angiogenesis. However, specific effects and mechanisms of HBO on limb ischaemia responding to a hypoxic environment remain largely unknown. We aimed to investigate the therapeutic potential of HBO i...

Full description

Saved in:
Bibliographic Details
Published in:Journal of cellular and molecular medicine 2024-12, Vol.28 (24), p.e70310
Main Authors: Lin, You-Cheng, Shih, Jhih-Yuan, Lin, Yu-Wen, Niu, Ko-Chi, Hong, Chon-Seng, Chen, Zhih-Cherng, Pan, Shin-Chen, Chang, Tzu-Yen, Kan, Wei-Chih, Chang, Wei-Ting
Format: Article
Language:English
Subjects:
Animals
Cell Movement
Cell Proliferation
Endothelial Cells - metabolism
Extremities - blood supply
Extremities - pathology
Hindlimb - blood supply
Human Umbilical Vein Endothelial Cells - metabolism
Humans
Hyperbaric Oxygenation - methods
Ischemia - metabolism
Ischemia - therapy
Male
Mice
Mice, Inbred C57BL
Neovascularization, Physiologic
Original
Reactive Oxygen Species - metabolism
Vascular Endothelial Growth Factor A - metabolism
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Hyperbaric oxygen (HBO) therapy has emerged as a potential treatment, shown to enhance blood flow and angiogenesis. However, specific effects and mechanisms of HBO on limb ischaemia responding to a hypoxic environment remain largely unknown. We aimed to investigate the therapeutic potential of HBO in the treatment of limb ischaemia. Following limb ischaemia surgery, we evaluated the angiogenic capacity in wild-type C57BL/6J mice subjected to HBO treatment (100% oxygen at 3 ATA for 1 h/day for five consecutive days) compared to untreated controls. Notably, through laser Doppler perfusion imaging and CD31 staining mice receiving HBO postlimb ischaemia surgery exhibited significantly enhanced angiogenic capability and reduced ROS expression compared to nontreated counterparts. Additionally, in vitro experiments were conducted to investigate whether HBO could mitigate endothelial cell dysfunction and reactive oxygen species (ROS) production triggered by oxygen-glucose deprivation (OGD). HBO treatment rescued the impaired proliferation, migration and tube formation of endothelial cells following OGD. Mechanistically, HBO upregulated the expression of proangiogenic proteins, including vascular endothelial growth factor (VEGF), haem oxygenase-1 (HO-1), hypoxia-inducible factor 1 (HIF-1) and nuclear factor erythroid 2-related factor 2 (Nrf2). Collectively, HBO treatment shows promise in augmenting the endogenous angiogenic potential and suppressing ROS levels in limb ischaemia.
ISSN:1582-4934
1582-1838
1582-4934
DOI:10.1111/jcmm.70310